Wonderland Switzerland AG v. Evenflo Company, Inc.

District Court, D. Delaware·Decided September 29, 2021·No. 1:18-cv-01990·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE

WONDERLAND SWITZERLAND AG,

Plaintiff,

v. Civil Action No. 18-1990-RGA

EVENFLO COMPANY, INC.,

Defendant.

MEMORANDUM OPINION

Steven J. Balick, Andrew C. Mayo, ASHBY & GEDDES, Wilmington, DE; Shamita Etienne- Cummings, David M. Tennant, WHITE & CASE, Washington, DC; Bijal Vakil, WHITE & CASE, Silicon Valley, CA.

Attorneys for Plaintiff.

Jack B. Blumenfeld, Jeremy A. Tigan, Sarah E. Simonetti, MORRIS NICHOLS ARSHT & TUNNELL LLP, Wilmington, DE; Jeffrey J. Lyons, BAKER & HOSTETLER LLP, Wilmington, DE; John M. Mueller, BAKER& HOSTETLER LLP, Cincinnati, OH.

Attorneys for Defendant.

September 29, 2021 /s/ Richard G. Andrews ANDREWS, U.S. DISTRICT JUDGE:

Before the Court is post-trial briefing regarding infringement, damages, and invalidity. (D.I. 175, 179, 176, 180, 181, 182). The briefing followed a four-day bench trial, held from Feb. 3, 2021 to Feb. 8, 2021. (D.I. 168–71, hereinafter referred to as “Tr.”). My findings of fact and conclusions of law follow. See Fed. R. Civ. P. 52(a). I. PROCEDURAL BACKGROUND Plaintiff Wonderland Switzerland AG filed this lawsuit against Defendants Evenflo Company, Inc. and Goodbaby U.S. Holdings1 on December 14, 2018, asserting infringement of U.S. Patent Nos. 7,862,117 (“the ’117 patent”), 8,087,725 (“the ’725 patent”), and 8,123,294 (“the ’294 patent”) (collectively, “the Asserted Patents”). (D.I. 1). II. FACTUAL BACKGROUND Plaintiff argues that Defendant’s EveryStage LX, DLX, and Gold models of car seats (“the accused product”) infringe claims 1, 6, 8, 10, 12, 13, and 15 of the ʼ294 patent, claim 1 of the ʼ725 patent, and claim 9 of the ʼ117 patent under 35 U.S.C. § 271. (D.I. 176 at 1). For purposes of evaluating infringement, the parties do not dispute that the three models are the same in the relevant features. (Tr. at 300:20–302:4). The ʼ117 and ʼ725 patents are titled “Headrest and Harness Adjustment for Child Car Seat” and share a common specification. (D.I. 1-1, Ex. A, B). The asserted apparatus claims of

these patents are directed to “transporting children in an automobile” using a “positionally adjustable head rest cooperable with a movable harness that relocates in response to the positional adjustment of the head rest.” (Id., Ex. A, at 2:47–51). The ʼ294 patent is titled

1 Goodbaby was terminated as a party when it was not named as a defendant in the First Amended Complaint. (D.I. 36). “Harness Storage System for Child Car Seats.” (Id., Ex. C). The asserted claims for the ʼ294 patent are directed to “a harness storage system in a child’s car seat to allow the five-point harness to be stowed out of the way without requiring the harness to be removed from the car seat shell.” (Id., Ex. C, at 2:13–16). Claims 13 and 15 are method claims; the rest are apparatus

claims. The accused product, the EveryStage, is a convertible car seat that can be used interchangeably in rear-facing, front-facing, and booster seat configurations. III. LEGAL STANDARD A. Literal Infringement A patent is infringed when a person “without authority makes, uses, offers to sell, or sells any patented invention, within the United States . . . during the term of the patent . . . .” 35 U.S.C. § 271(a). A two-step analysis is employed in making an infringement determination. See Markman v. Westview Instruments, Inc., 52 F.3d 967, 976 (Fed. Cir. 1995) (en banc), aff’d, 517 U.S. 370 (1996). First, the court must construe the asserted claims to ascertain their meaning and scope. See id. The trier of fact must then compare the properly construed claims with the

accused infringing product. See id. at 976. This second step is a question of fact. See Bai v. L & L Wings, Inc., 160 F.3d 1350, 1353 (Fed. Cir. 1998). “Literal infringement of a claim exists when every limitation recited in the claim is found in the accused device.” Kahn v. Gen. Motors Corp., 135 F.3d 1472, 1477 (Fed. Cir. 1998). “If any claim limitation is absent from the accused device, there is no literal infringement as a matter of law.” Bayer AG v. Elan Pharm. Research Corp., 212 F.3d 1241, 1247 (Fed. Cir. 2000). If an accused product does not infringe an independent claim, it also does not infringe any claim depending thereon. See Wahpeton Canvas Co. v. Frontier, Inc., 870 F.2d 1546, 1553 (Fed. Cir. 1989). However, “[o]ne may infringe an independent claim and not infringe a claim dependent on that claim.” Monsanto Co. v. Syngenta Seeds, Inc., 503 F.3d 1352, 1359 (Fed. Cir. 2007) (internal quotations omitted). The patent owner has the burden of proving infringement and must meet its burden by a preponderance of the evidence. See SmithKline Diagnostics, Inc. v. Helena Lab. Corp., 859 F.2d 878, 889 (Fed. Cir. 1988) (citations omitted).

B. Doctrine of Equivalents A product that does not literally infringe a patent claim may still infringe under the doctrine of equivalents if the differences between an individual limitation of the claimed invention and an element of the accused product are insubstantial. See Warner–Jenkinson Co. v. Hilton Davis Chem. Co., 520 U.S. 17, 24 (1997). Alternatively, an element in an accused product can be shown to infringe under the doctrine of equivalents if that element “performs substantially the same function [as the missing limitation] in substantially the same way to obtain substantially the same result.” Voda v. Cordis Corp., 536 F.3d 1311, 1326 (Fed. Cir. 2008) (quotations and citations omitted). C. Induced Infringement

Free access — add to your briefcase to read the full text and ask questions with AI

Wonderland Switzerland AG v. Evenflo Company, Inc., (D. Del. 2021).

Wonderland Switzerland AG v. Evenflo Company, Inc. (Wonderland Switzerland AG v. Evenflo Company, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Dunlap v. Schofield
152 U.S. 244 (Supreme Court, 1894)
Graham v. John Deere Co. of Kansas City
383 U.S. 1 (Supreme Court, 1966)
Warner-Jenkinson Co. v. Hilton Davis Chemical Co.
520 U.S. 17 (Supreme Court, 1997)
KSR International Co. v. Teleflex Inc.
550 U.S. 398 (Supreme Court, 2007)
Uniloc USA, Inc. v. Microsoft Corp.
632 F.3d 1292 (Federal Circuit, 2011)
Lucent Technologies, Inc. v. Gateway, Inc.
580 F.3d 1301 (Federal Circuit, 2009)
Voda v. Cordis Corp.
536 F.3d 1311 (Federal Circuit, 2008)
Monsanto Co. v. Syngenta Seeds, Inc.
503 F.3d 1352 (Federal Circuit, 2007)
Leonard R. Kahn v. General Motors Corporation
135 F.3d 1472 (Federal Circuit, 1998)
Laserdynamics, Inc. v. Quanta Computer, Inc.
694 F.3d 51 (Federal Circuit, 2012)
Mirror Worlds, LLC v. Apple Inc.
692 F.3d 1351 (Federal Circuit, 2012)
Inre: Steve Morsa
713 F.3d 104 (Federal Circuit, 2013)
Georgia-Pacific Corp. v. United States Plywood Corp.
318 F. Supp. 1116 (S.D. New York, 1970)
Intouch Technologies, Inc. v. Vgo Communications, Inc.
751 F.3d 1327 (Federal Circuit, 2014)